“Myriocin was approved by the United States Food and Drug Administration (FDA) under the names, “ISP-1” and “FTY720” and is now an oral drug used for inflammatory demyeli- nating diseases including multiple sclerosis”
A new mechanism of aging has been uncovered by researchers: the accumulation of sphingolipids. Ceramides, a widely known class of sphingolipids, build up in aging muscle and reduce its function, impacting the functional capacity of older adults. These findings inspire the development of potential drugs for the treatment of aging.